The Road Ahead 7/7/23
Halftime Report
00:00
Biogen Shares Fall Despite FDA Approval for Its Alzheimer's Treatment
Biogen falling today despite the company's Alzheimer drug getting FDA approval this week. Merck is one of our favorite names for sure, we've owned it for over 10 years. UnitedHealthcare may be in a little bit of trouble as you head into a presidential election year.
Transcript
Play full episode
